GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » BIMI Holdings Inc (STU:63N) » Definitions » EV-to-EBITDA

BIMI Holdings (STU:63N) EV-to-EBITDA : -2.05 (As of Jun. 08, 2024)


View and export this data going back to . Start your Free Trial

What is BIMI Holdings EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, BIMI Holdings's enterprise value is €21.01 Mil. BIMI Holdings's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 was €-10.27 Mil. Therefore, BIMI Holdings's EV-to-EBITDA for today is -2.05.

The historical rank and industry rank for BIMI Holdings's EV-to-EBITDA or its related term are showing as below:

STU:63N' s EV-to-EBITDA Range Over the Past 10 Years
Min: -114.82   Med: -0.75   Max: 262.45
Current: -2.1

During the past 13 years, the highest EV-to-EBITDA of BIMI Holdings was 262.45. The lowest was -114.82. And the median was -0.75.

STU:63N's EV-to-EBITDA is ranked worse than
100% of 463 companies
in the Healthcare Providers & Services industry
Industry Median: 12.84 vs STU:63N: -2.10

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-08), BIMI Holdings's stock price is €1.68. BIMI Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 was €-2.794. Therefore, BIMI Holdings's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


BIMI Holdings EV-to-EBITDA Historical Data

The historical data trend for BIMI Holdings's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BIMI Holdings EV-to-EBITDA Chart

BIMI Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EV-to-EBITDA
Get a 7-Day Free Trial Premium Member Only Premium Member Only -558.56 -18.87 -8.48 -0.81 -0.50

BIMI Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.62 -0.50 -0.40 -1.28 -1.41

Competitive Comparison of BIMI Holdings's EV-to-EBITDA

For the Pharmaceutical Retailers subindustry, BIMI Holdings's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BIMI Holdings's EV-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, BIMI Holdings's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where BIMI Holdings's EV-to-EBITDA falls into.



BIMI Holdings EV-to-EBITDA Calculation

BIMI Holdings's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=21.013/-10.265
=-2.05

BIMI Holdings's current Enterprise Value is €21.01 Mil.
BIMI Holdings's EBITDA for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-10.27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BIMI Holdings  (STU:63N) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

BIMI Holdings's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=1.68/-2.794
=At Loss

BIMI Holdings's share price for today is €1.68.
BIMI Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-2.794.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


BIMI Holdings EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of BIMI Holdings's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


BIMI Holdings (STU:63N) Business Description

Traded in Other Exchanges
Address
Chongqing Corporation Avenue, 9th Floor, Building 2, Yuzhong District, Chongqing, CHN, 400010
BIMI International Medical Inc is a healthcare product and provider, offering a broad range of healthcare products and related services and operates private hospitals in China. The company is engaged in four business segments, Pharmaceuticals wholesale, Medical devices wholesale, Medical services, and Pharmacy retail. It generates maximum revenue from the pharmaceuticals wholesale segment. It mainly sources its products from large state-owned pharmaceutical manufacturers and wholesalers and mid-sized or small private pharmaceutical manufacturers and wholesalers. The Company's revenues were generated in the PRC.

BIMI Holdings (STU:63N) Headlines

No Headlines